When is imaging needed to assess the response to treatment in cardiac amyloidosis.

Journal: Current opinion in cardiology
Published Date: May 22, 2025

Abstract

PURPOSE OF REVIEW: Cardiac amyloidosis is characterized by systolic and diastolic abnormalities due to deposition of amyloid fibril within the myocardial extracellular space. Technological advances in multimodality cardiac imaging now helps in accurate diagnosis and prognosis of this disease. With technological advances in imaging, it is now easier to follow up these patients whether they are getting response to therapy.

Authors

  • Shantanu P Sengupta
    Sengupta Hospital and Research Institute, Nagpur, Maharashtra.
  • Prayag Kini
    Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru, Karnataka, India.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals